{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:16:33Z","timestamp":1789924593882,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T00:00:00Z","timestamp":1401926400000},"content-version":"vor","delay-in-days":3687,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.ejvs.2003.12.025","type":"journal-article","created":{"date-parts":[[2004,1,15]],"date-time":"2004-01-15T05:19:27Z","timestamp":1074143967000},"page":"456-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Aspirin Resistance in Cardiovascular Disease: A Review"],"prefix":"10.1016","volume":"27","author":[{"given":"S","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Appleberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2003.12.025_BIB1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0002-9149(99)00049-1","article-title":"Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb\/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy","volume":"83","author":"Alexander","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1056\/NEJM198801283180431","article-title":"Preliminary report. Findings from the aspirin component of the ongoing Physicians' Health Study","volume":"318","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians' Health Study","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB5","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/bmj.308.6922.159","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2014II: maintenance of vascular graft or arterial patency by antiplatelet therapy","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2014I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4615-5325-0_15","article-title":"X-ray crystallographic study of the structure of prostaglandin H synthase","volume":"400A","author":"Picot","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB10","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1021\/bi952776w","article-title":"Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site","volume":"35","author":"Loll","year":"1996","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/107602969600200108","article-title":"Clopidogrel: an antithrombotic drug acting on the ADP dependent pathway of human platelets","volume":"2","author":"Savi","year":"1996","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0022-3565(25)38762-8","article-title":"Binding of [3H]-2-methylthio ADP to rat platelets\u2014effect of clopidogrel and ticlopidine","volume":"269","author":"Savi","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB13","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/01.STR.24.10.1452","article-title":"Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The ticlopidine aspirin stroke study","volume":"24","author":"Bellavance","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0008-6363(01)00452-7","article-title":"Tissue factor and coronary artery disease","volume":"53","author":"Moons","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1015324310374","article-title":"Possible mechanisms of aspirin resistance","volume":"13","author":"Cambria-Kiely","year":"2002","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0049-3848(02)00210-4","article-title":"Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate","volume":"107","author":"Macchi","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB19","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/09537100120104890","article-title":"Towards a definition of aspirin resistance: a typological approach","volume":"13","author":"Weber","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB21","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/01.STR.25.12.2331","article-title":"Development of aspirin resistance in persons with previous ischemic stroke","volume":"25","author":"Helgason","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB22","first-page":"221","article-title":"Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically","volume":"11","author":"Buchanan","year":"1995","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB23","first-page":"801","article-title":"Population variability in the effect of aspirin on platelet function. Implications for clinical trials and therapy","volume":"118","author":"Pappas","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0049-3848(91)90085-B","article-title":"Effects of acetylsalicylic acid in stroke patients. Evidence of nonresponders in a subpopulation of treated patients","volume":"63","author":"Grotemeyer","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB26","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1055\/s-0038-1657677","article-title":"Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty","volume":"78","author":"Mueller","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1358863X9300400102","article-title":"The epidemiology of peripheral arterial disease","volume":"4","author":"Leng","year":"1993","journal-title":"Vasc Med Rev"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB28","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1161\/01.CIR.92.9.2432","article-title":"Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin","volume":"92","author":"Hung","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.CIR.102.8.840","article-title":"Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis","volume":"102","author":"Belton","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenase 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB31","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1161\/01.CIR.0000015422.86569.52","article-title":"Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?","volume":"105","author":"Halushka","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1182\/blood.V78.1.154.154","article-title":"Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment","volume":"78","author":"Valles","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.CIR.95.1.63","article-title":"Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin","volume":"95","author":"Santos","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB34","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/hc4701.099787","article-title":"Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury","volume":"104","author":"Undas","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0049-3848(98)00042-5","article-title":"Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young Central Europeans","volume":"90","author":"Sperr","year":"1998","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB36","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.CIR.102.9.1007","article-title":"Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina","volume":"102","author":"Cipollone","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB37","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/01.STR.31.3.591","article-title":"Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin","volume":"31","author":"Kawasaki","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB38","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1067\/mtc.2001.111416","article-title":"Aspirin resistance after coronary artery bypass grafting","volume":"121","author":"Zimmermann","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/14017439850140021","article-title":"The effect of different antithrombotic regimens on platelet aggregation after myocardial infarction","volume":"32","author":"Hurlen","year":"1998","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/sj.bjp.0704248","article-title":"Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro","volume":"134","author":"Zhao","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0049-3848(02)00405-X","article-title":"Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease","volume":"108","author":"Andersen","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-995840","article-title":"PFA-100 system: a new method for assessment of platelet dysfunction","volume":"24","author":"Mammen","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000236474","article-title":"Control of the circulation by endothelial mediators. Inaugural G.B. West Memorial Lecture","volume":"101","author":"Vane","year":"1993","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-995840","article-title":"PFA-100 system: a new method for assessment of platelet dysfunction","volume":"24","author":"Mammen","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0037-1613805","article-title":"Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100","volume":"83","author":"Homoncik","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0049-3848(02)00391-2","article-title":"PFA-100\u2122 and flow cytometry: can they challenge aggregometry to assess antiplatelet agents, other than GPIIbIIIa blockers, in coronary angioplasty?","volume":"108","author":"H\u00e9zard","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-2999(02)02956-4","article-title":"Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease","volume":"462","author":"Malinin","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/107602960300900208","article-title":"Value of thromboelastography in the assessment of platelet function","volume":"9","author":"Bowbrick","year":"2003","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB49","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1378\/chest.119.1_suppl.39S","article-title":"Platelet-active drugs: the relationships among dose, effectiveness, and side effects","volume":"119","author":"Patrono","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB50","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/bmj.296.6618.316","article-title":"United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results","volume":"296","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB51","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","article-title":"The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results","volume":"54","author":"Farrell","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9149(97)00316-0","article-title":"Effect of aspirin dosage and enteric coating on platelet reactivity","volume":"80","author":"Feng","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1592\/phco.23.5.579.32206","article-title":"Aspirin dosage and thromboxane synthesis in patients with vascular disease","volume":"23","author":"Hart","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB54","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/01.CIR.89.5.1951","article-title":"Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin","volume":"89","author":"Larsson","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB55","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/01.CIR.100.13.1374","article-title":"Evidence for prothrombotic effects of exercise and limited protection by aspirin","volume":"100","author":"Li","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB56","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0049-3848(00)00277-2","article-title":"Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin","volume":"99","author":"Hurlen","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB57","doi-asserted-by":"crossref","DOI":"10.1016\/S0049-3848(03)00008-2","article-title":"Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease","author":"Christiaens","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB58","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00415-003-0954-y","article-title":"Aspirin non-responder status in patients with recurrent cerebral ischemic attacks","volume":"250","author":"Grundmann","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.ejvs.2003.12.025_BIB60","first-page":"1385","article-title":"Results of the BRAT study\u2014a pilot study investigating the possible significance of ASA non-responsiveness on the benefits and risks of ASA on thrombosis in patients undergoing coronary artery bypass surgery","volume":"16","author":"Buchanan","year":"2000","journal-title":"Can J Cardiol"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107858840300604X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107858840300604X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:34:50Z","timestamp":1761042890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107858840300604X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S107858840300604X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2003.12.025","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin Resistance in Cardiovascular Disease: A Review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2003.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}